BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31587803)

  • 1. [Are there still indications of lymph node dissection in epithelial ovarian cancers after the LION trial?].
    Azaïs H; Canlorbe G; Nikpayam M; Gonthier C; Belghiti J; Uzan C
    Bull Cancer; 2020 Jun; 107(6):707-714. PubMed ID: 31587803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Bull Cancer; 2019 Apr; 106(4):354-370. PubMed ID: 30850152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bolze PA; Collinet P; Golfier F; Bourgin C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].
    Lavoué V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lécuru F; Lefrère-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Sénéchal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):100-110. PubMed ID: 30686724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Ferron G; Narducci F; Pouget N; Touboul C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
    Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
    J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Surgical Management of Advanced Stages of Borderline Ovarian Tumours].
    Raimond E; Bourdel N
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):304-313. PubMed ID: 32004785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prise en charge chirurgicale du cancer épithélial de l'ovaire - première ligne et première rechute: Surgical management of epithelial ovarian cancer - first line and first relapse.
    Classe JM; Joly F; Lécuru F; Morice P; Pomel C; Selle F; You B
    Bull Cancer; 2021 Dec; 108(9S1):S13-S21. PubMed ID: 34955158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.
    Harter P; Gnauert K; Hils R; Lehmann TG; Fisseler-Eckhoff A; Traut A; du Bois A
    Int J Gynecol Cancer; 2007; 17(6):1238-44. PubMed ID: 17433064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
    Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
    Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-aortic lymphadenectomy below inferior mesenteric artery versus renal vessels in stage IIIC epithelial ovarian cancer: A comparison of surgical outcomes.
    Zhu C; Zhu H; Wang Y; Cui H; Li Y
    Int J Gynaecol Obstet; 2020 Feb; 148(2):192-197. PubMed ID: 31746467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
    Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
    Benedetti Panici P; Giannini A; Fischetti M; Lecce F; Di Donato V
    Curr Oncol Rep; 2020 Feb; 22(3):22. PubMed ID: 32036457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.